Updated on 04.07.2025

EXECUTIVE ORDER 14257 – NEW TARIFFS AND OUR ONGOING SUPPORT

President Trump recently signed Executive Order 14257, establishing a new reciprocal tariff policy that will impact a broad range of imports into the United States. This policy imposes an additional 10% duty on most imported goods starting April 5, 2025, with higher country-specific tariffs set to take effect on April 9.

While certain critical products, including many pharmaceutical and life sciences inputs, are exempt under Annex II of the Order, the scope of affected goods is extensive and evolving. We understand the challenges these changes may present and want to reassure you that Marken remains fully committed to supporting your operations throughout this transition period.

We want to highlight the following key areas of ongoing support:

1. Regular Trade Updates
   We will continue to provide timely updates as new tariff measures are implemented or modified. The executive order provides a policy framework, but Customs procedures and regulatory updates have not yet been finalized. Implementation will be dynamic.
2. Strategic Guidance on Duty Mitigation
   We will remain available to assist with identifying potential strategies for managing or reducing tariff exposure, which includes eligibility for duty exemptions, tariff classification reviews, sourcing evaluations, and participation in savings programs where applicable.
3. Continued Facilitation of Imports
   To avoid disruptions in your supply chain, we will continue to offer pre-outlays of duties and taxes on your behalf, consistent with our established policies. Please note that all disbursements will remain subject to our standard terms, including applicable disbursement fees, transaction thresholds, and credit review.

Marken stays committed to supporting clients in navigating the regulatory and trade landscape of the global clinical supply chain. For more information or if you have any questions, contact our team at TradeCompliance@marken.com.

Updated on 03.07.2025

The U.S. government has issued new amendments to the additional tariffs on imports from Mexico and Canada that go into effective March 7, 2025. Under these updates, goods that qualify for preferential treatment under the United States-Mexico-Canada Agreement (USMCA) will now be exempt from the additional duties that were implemented on March 4, 2025.

Below is a breakdown of how these changes affect imports from Canada and Mexico.

What’s Changing?

As of March 7, 2025, imports from Mexico and Canada that qualify for USMCA are no longer subject to the additional duties that were imposed on March 4, 2025.

• Canadian-origin products that qualify for USMCA will no longer be subject to the 25% additional duty.
• Mexican-origin products that qualify for USMCA will no longer be subject to the 25% additional duty.

To reflect this change, new HTSUS classifications have been introduced:

• HTSUS 9903.01.14 – Applies to Canadian-origin goods that qualify for USMCA.
• HTSUS 9903.01.04 – Applies to Mexican-origin goods that qualify for USMCA.

Any products that meet the USMCA rules of origin and are entered free of duty under the terms of General Note 11 of the HTSUS will not be subject to the additional valorem duty rates outlined in the previous Executive Orders.

What Importers Need to Do?

• Review USMCA Eligibility – Ensure that your goods meet USMCA rules of origin and qualify for duty-free treatment under General Note 11 of the HTSUS.
• Use the Correct HTSUS Classifications – When filing entries, use HTSUS 9903.01.14 (Canada)

or HTSUS 9903.01.04 (Mexico) for eligible goods to claim exemption from the additional duties.

• Adjust Import Compliance Procedures – Work with Customs brokers and logistics teams to ensure shipments are properly documented for USMCA qualification to avoid unnecessary duties.

The USMCA exemption from the additional Mexico and Canada tariffs is a major relief for importers who rely on duty-free treatment under the trade agreement. Businesses should act quickly to confirm their goods qualify for USMCA and update compliance procedures to avoid overpaying on duties.

Marken stays committed to supporting clients in navigating the regulatory and trade landscape of the global clinical supply chain. For more information or if you have any questions, contact our team at TradeCompliance@marken.com.

Updated on 03.04.2025

Effective March 4, 2025, at 12:01 a.m. Eastern Standard Time (EST), the U.S. government imposed new import duties on products from Mexico, Canada and China. These tariffs significantly increase costs for importers, adding:

• 25% duties on most imports from Mexico and Canada
• 20% duties on most imports from China (including Hong Kong) 

If your business imports from any of these countries, it’s crucial to understand how these changes will impact costs, supply chains, and compliance requirements. Here’s what you need to know to stay compliant.

New Tariffs on Imports from Mexico

Most goods from Mexico face a 25% additional duty when imported into the U.S.

Key Details:

• Tariff applies to most Mexican-origin products
• Certain humanitarian donations and informational materials are exempt
• The de minimis exemption (for low-value shipments) remains in place for now but could be revoked later
• Goods in Foreign Trade Zones (FTZs) must be admitted under privileged foreign status to ensure proper duty application
• No duty drawback will be allowed for these tariffs

Importers should review their product classifications and assess cost impacts now to avoid surprises at customs.

New Tariffs on Imports from Canada

Most goods from Canada face a 25% additional duty when imported into the U.S.

Key Details:

• Tariff applies to most Canadian-origin products
• Certain humanitarian donations and informational materials are exempt
• The de minimis exemption (for low-value shipments) remains in place for now but could be revoked later
• Goods in Foreign Trade Zones (FTZs) must be admitted under privileged foreign status to ensure proper duty application
• No duty drawback will be allowed for these tariffs

Importers should review their product classifications and assess cost impacts now to ensure compliance.

New Tariffs on Imports from China (Including Hong Kong)

Most goods from China (including Hong Kong) face a 20% additional duty when imported into the U.S.

Key Details:

• Tariff applies to most Chinese-origin products, including those from Hong Kong
• The de minimis exemption (for low-value shipments) remains in place for now but could be revoked later
• Goods in Foreign Trade Zones (FTZs) must be admitted under privileged foreign status to ensure proper duty application
• No duty drawback will be allowed for these tariffs
• Goods in transit before February 1, 2025, may qualify for a temporary exemption if properly certified by the importer

Importers should review their product origin and adjust supply chain strategies to minimize costs.

What Importers Need to Do

To stay compliant and manage costs, importers should:

• Confirm Country of Origin – Ensure your goods are correctly identified as products of Mexico or Canada under CBP’s country-of-origin rules, as this determines whether the new tariffs apply.
• Assess Cost Impact – Factor in the 25% duty increase when budgeting and pricing.
• Monitor the De Minimis Exemption – While still available, this exemption could be revoked later.
• Check Foreign Trade Zone (FTZ) Entries – Goods from Mexico and Canada must be entered under privileged foreign status to ensure correct duty application.
• Adjust Supply Chain Strategies – Consider alternative sourcing or duty mitigation strategies to reduce impact.

Marken stays committed to supporting clients in navigating the regulatory and trade landscape of the global clinical supply chain. For more information or if you have any questions, contact our team at TradeCompliance@marken.com.